Antimicrobial compositions containing colloids of oligodynamic metals

• US 7,179,849 B2
• Filed: 08/26/2003
• Issued: 02/20/2007
• Est. Priority Date: 12/15/1999
• Status: Expired due to Term

• Current Assignee: C.R. Bard, Inc. (Becton, Dickinson & Co)
• Original Assignee: C.R. Bard, Inc. (Becton, Dickinson & Co)
• Inventors: Terry, Richard N.
• Primary Examiner(s): SZEKELY, PETER A
• Application Number:
  US10/649,595
• Publication Number:
  US 20040116551A1
• Time in Patent Office: 1,274 Days
• Field of Search: 523/122, 524398-400, 524/403, 524/413, 524430-437, 427/379, 427/385.5, 427386-387, 427/2.28, 604/264
• US Class Current: 523/122
• CPC Class Codes: A01N 2300/00 Combinations or mixtures of active ingredients covered by classes A01N27/00 - A01N65/48 with other active or formulation relevant ingredients, e.g. specific carrier materials or surfactants, covered by classes A01N25/00 - A01N65/48
• CPC Class Codes: A01N 25/04 Dispersions, emulsions, suspoemulsions, suspension concentrates or gels foams A01N25/16
• CPC Class Codes: A01N 25/10 Macromolecular compounds
• CPC Class Codes: A01N 25/34 Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
• CPC Class Codes: A01N 59/16 Heavy metals; Compounds thereof
• CPC Class Codes: A61L 2/238 Metals or alloys, e.g. oligodynamic metals
• CPC Class Codes: A61L 2300/102 Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
• CPC Class Codes: A61L 2300/104 Silver, e.g. silver sulfadiazine
• CPC Class Codes: A61L 2300/404 Biocides, antimicrobial agents, antiseptic agents
• CPC Class Codes: A61L 2300/602 Type of release, e.g. controlled, sustained, slow
• CPC Class Codes: A61L 2300/606 Coatings
• CPC Class Codes: A61L 2300/62 Encapsulated active agents, e.g. emulsified droplets
• CPC Class Codes: A61L 27/34 Macromolecular materials
• CPC Class Codes: A61L 27/54 Biologically active materials, e.g. therapeutic substances A61L27/227 takes precedence
• CPC Class Codes: A61L 29/08 Materials for coatings
• CPC Class Codes: A61L 29/085 Macromolecular materials
• CPC Class Codes: A61L 29/16 Biologically active materials, e.g. therapeutic substances A61L29/048 takes precedence
• CPC Class Codes: A61L 31/10 Macromolecular materials
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence
• CPC Class Codes: A61M 2025/0056 provided with an antibacterial agent, e.g. by coating, residing in the polymer matrix or releasing an agent out of a reservoir
• CPC Class Codes: A61P 31/00 : Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
• CPC Class Codes: C08K 3/08 : Metals
• CPC Class Codes: C08L 2666/04 : Macromolecular compounds according to groups C08L7/00 - C08L49/00, or C08L55/00 - C08L57/00; Derivatives thereof
• CPC Class Codes: C08L 2666/54 : Inorganic substances
• CPC Class Codes: C08L 27/06 : Homopolymers or copolymers of vinyl chloride
• CPC Class Codes: C09D 175/08 : from polyethers
• CPC Class Codes: Y10T 428/31551 : Of polyamidoester [polyurethane, polyisocyanate, polycarbamate, etc.]
• CPC Class Codes: Y10T 428/31609 : Particulate metal or metal compound-containing
• CPC Class Codes: Y10T 428/31663 : As siloxane, silicone or silane

Abstract

The present invention relates to antimicrobial compositions, methods for the production of these compositions, and use of these compositions with medical devices, such as catheters, and implants. The compositions of the present invention advantageously provide varying release kinetics for the active ions in the compositions due to the different water solubilities of the ions, allowing antimicrobial release profiles to be tailored for a given application and providing for sustained antimicrobial activity over time. More particularly, the invention relates to polymer compositions containing colloids comprised of salts of one or more oligodynamic metal, such as silver. The process of the invention includes mixing a solution of one or more oligodynamic metal salts with a polymer solution or dispersion and precipitating a colloid of the salts by addition of other salts to the solution which react with some or all of the first metal salts. The compositions can be incorporated into articles or can be employed as a coating on articles such as medical devices. Coatings may be on all or part of a surface.

Claims

1. A composition comprising:

at least one polymer;

a colloid comprising a plurality of oligodynamic metal compounds, wherein the oligodynamic metal compounds are a plurality of oligodynamic metal salts, a plurality of oligodynamic metal oxides, or at least one oligodynamic metal salt and at least one oligodynamic metal oxide, and wherein the oligodynamic metal compounds inhibit microbial adherence of one or more organisms to the composition; and

at least one active agent in addition to the oligodynamic metal compounds.

2. The composition of claim 1, wherein the oligodynamic metal compounds create a zone of inhibition to the one or more pathogens when placed on a culture of the one or more pathogens.

3. The composition of claim 1, wherein the oligodynamic metal compounds do not create a zone of inhibition to the one or more pathogens when placed on a culture of the one or more pathogens.

4. The composition of claim 1, wherein the oligodynamic metal compounds comprise a silver salt.

5. The composition of claim 4, wherein the silver salt is chosen from:

silver chloride, silver iodide, silver citrate, silver lactate, silver acetate, silver propionate, silver salicylate, silver bromide, silver ascorbate, silver laurel sulfate, silver phosphate, silver sulfate, silver oxide, silver benzoate, silver carbonate, silver sulfadiazine, or silver gluconate.

6. The composition of claim 1, wherein the oligodynamic metal salt comprises a plurality of salts having different solubilities in water.

7. The composition of claim 1, wherein the polymer is chosen from:

polyurethanes, polyvinylpyrrolidones, polyvinyl alcohols, polyethylene glycols, polypropylene glycols, polyoxyethylenes, polyacrylic acid, polyacrylamide, carboxymethyl cellulose, dextrans, polysaccharides, starches, guar, xanthan and other gums, collagen, gelatins, biological polymers, polytetrafluoroethylene, polyvinyl chloride, polyvinylacetate, poly(ethylene terephthalate), silicone, polyesters, polyamides, polyureas, styrene-block copolymers, polymethyl methacrylate, polyacrylates, acrylic-butadiene-styrene copolymers, polyethylene, polystyrene, polypropylene, natural and synthetic rubbers, acrylonitrile rubber, cellulose, or mixtures, derivatives, or copolymers thereof.

8. The composition of claim 4, wherein the silver salt is silver chloride and the composition contains silver chloride present in an amount from about four to about six percent based on the total weight of solids in the composition.

9. The composition of claim 1, wherein the at least one active agent is chosen from:

antibacterial agents, immune boosting agents, anticancer agents, angiogenic agents, polymyxins, antifungal agents, antiviral agents, antibiotics, growth factors, cytokines, immunoglobulins, pharmaceuticals, nutraceuticals, antithrombogenic agents, antitumoral agents, growth factors, antiangiogenic agents, spermicides, anesthetics, analgesics, vasodilation substances, wound healing agents, plant extracts, herbicides, insecticides, algaecides, antifoulants, antifogging agents, UV screening agents, or combinations thereof.

10. The composition of claim 1, wherein the active agents are present in a concentration from about 0 1% to about 50% of the dry weight of the composition.

11. The composition of claim 1, wherein the active agents are present in a concentration from about 1% to 30% of the dry weight of the composition.

12. The composition of claim 1, wherein the active agents are chosen from:

biguanides, chlorinated phenols, quaternary ammonium compounds, growth factors, cytokines, immunoglobulins, pharmaceutical agents, or combinations thereof.

13. The composition of claim 12, wherein the biguanides are chosen from:

poly (hexamethylene biguanide) hydrochloride, a chlorhexidine compound, or combinations thereof.

14. The composition of claim 13, wherein the chlorhexidine compound is chosen from:

chlorhexidine diphosphanilate, chlorhexidine digluconate, chlorhexidine diacetate, chlorhexidine dihydrochloride, chlorhexidine dichloride, chlorhexidine dihydroiodide, chlorhexidine diperchlorate, chlorhexidine dinitrate, chlorhexidine sulfate, chlorhexidine sulfite, chlorhexidine thiosulfate, chlorhexidine di-acid phosphate, chlorhexidine difluorophosphate, chlorhexidine diformate, chlorhexidine dipropionate, chlorhexidine di-iodobutyrate, chlorhexidine di-n-valerate, chlorhexidine dicaproate, chlorhexidine malonate, chlorhexidine succinate, chlorhexidine succinamate, chlorhexidine malate, chlorhexidine tartrate, chlorhexidine dimonoglycolate, chlorhexidine mono-diglycolate, chlorhexidine dilactate, chlorhexidine di-α

-hydroxyisobutyrate, chlorhexidine diglucoheptonate, chlorhexidine di-isothionate, chlorhexidine dibenzoate, chlorhexidine dicinnamate, chlorhexidine dimandelate, chlorhexidine di-isophthalate, chlorhexidine isoethionate chlorhexidine di-2-hydroxy-napthoate, chlorhexidine embonate, or combinations thereof.

15. The composition of claim 13, wherein the chlorhexidine compound is a chlorhexidine salt chosen from:

acetates, formates, gluconates, hydrochlorides, isoethionates, lactates, or succinamates of chlorhexidine.

16. The composition of claim 12, wherein the chlorinated phenols are chosen from:

parachlorometaxylenol, dichlorometaxylenol, triclosan (2,4,4′

-trichloro-2 hydroxy di-phenyl ether), 2-chlorophenol, 3-chlorophenol, 4-chlorophenol, 2,4-dichlorophenol, 2,4,6-trichlorophenol, 2,3,4,6-tetrachlorophenol, pentachlorophenol, 4-chlororesorcinol, 4,6-dichlororesorcinol, 2,4,6-trichlororesorcinol, p-alkyl-o-chlorophenols, o-alkyl-p-chlorophenols, dialkyl-4-chlorophenol, tri-alkyl-4-chlorophenol, dichloro-m-xylenol, chlorocresol, o-benzyl-p-chlorophenol, 3,4,6-trichlorphenol, 4-chloro-2-phenylphenol, 6-chloro-2-phenylphenol, o-benzyl-p-chlorophenol, 2,4-dichloro-3,5-diethylphenol, or combinations thereof.

17. The composition of claim 12, wherein the quaternary ammonium compounds are chosen from:

benzalkonium chloride, benzethonium chloride, other benzalkonium or benzethonium halides, cetylpyridinium chloride, dequalinium chloride, N-myristyl-N-methylmorpholinium methyl sulfate, poly[N-[3-(dimethylammonio)propyl]-N′

-[3-(ethyleneo-xyethylene dimethylammonio)propyl]urea dichloride], alpha-4-[1-tris(2-hydroxyethyl)ammonium chloride-2-butenyl]-omega-tris(2-hydroxyethyl)ammonium chloride, alpha-4-[1-tris(2-hydroxyethyl)ammonium chloride-2-butenyl]poly[1-dimethyl ammonium chloride-2-butenyl]-omega-tri-s(2-hydroxyethyl)ammonium chloride, poly [oxy-ethylene(dimethyliminio)ethylene (dimethyliminio)-ethylene dichloride], ethyl hexadecyl dimethyl ammonium ethyl sulfate, dimethyl ammonium ethyl sulfate, dimethylethylbenzyl ammonium chloride, dimethylbenzyl ammonium chloride, cetyldimethylethyl ammonium bromide, or combinations thereof.

18. The composition of claim 1, wherein the active agents are antimicrobial, antiinfective, antiviral, and antibacterial agents chosen from:

alexidine, gentamicin, tobramycin, amoxicillin, amphotericin, ampicillin, bacitracin, beclomethasone, benzocaine, benzoic acid, pipracil, aztneonam, betamethasone, biaxin, ceftazidime, cetrimide, chloramphenicol, clarithromycin, clotrimazole, cyclosporin, docycline, erythromycin, ethylenediamine tetraacetic acid (EDTA), furazolidine, fusidic acid, gramicidin, povidone iodine, pluronic-lodine complex, macrolides, miconazole, minocycline, neomycin, nystatin, octenidine hydrochloride, ofloxacin, parachlorometaxylene, penicillin, pentoxifylline, phenolic compounds, phenoxymethylpenicillin, picloxydine, polymixin, norfloxacin, oxolinic acid, ciprofloxacin;

pefloxacin, enoxacin, AM-833, pipemidic acid, piromidic acid, 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-4-oxo-7-(4-methyl-1-piperazinyl)-quinoline-3-carboxylic acid, naladixic acid, rifampicin, sorbic acid, sulfamylon, sulfonamides, tetracycline, triclocarban, vancomycins, zithromax, derivatives, metabolites, salts or mixtures thereof.

19. The composition of claim 12, wherein the growth factors are chosen from:

transforming growth factor-α

(“

TGF-α

”

), transforming growth factor-β

(“

TGF-β

”

), vascular epithelial growth factor (“

VEGF”

), basic fibroblast growth factor, insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), or mixtures thereof.

20. The composition of claim 12, wherein the cytokines are chosen from:

IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12, IL-13, TNF-α

, TNF-β

, or combinations thereof.

21. The composition of claim 12, wherein the immunoglobulins are chosen from:

IgG, IgA, IgM, IgD, IgE, or mixtures thereof.

22. The composition of claim 12, wherein pharmaceutical agents are chosen from:

nonoxynol 9, acebutolol, acetylcysteine, acetylsalicylic acid, acyclovir, AZT, alprazolam, alfacalcidol, allantoin, allopurinol, ambroxol, amikacin, amiloride, aminoacetic acid, aminodarone, amitriptyline, amlodipine, ascorbic acid, aspartame, astemizole, atenolol, benserazide, bezafibrate, biotin, biperiden, bisoprolol, bromazepam, bromhexine, bromocriptine, budesonide, bufexamac, buflomedil, buspirone, caffeine, camphor, captopril, carbamazepine, carbidopa, carboplatin, cefachlor, cefalexin, cefatroxil, cefazolin, cefixime, cefotaxime, ceftazidime, ceftriaxone, cefuroxime, selegiline, chloramphenicol, chlor-pheniramine, chlortalidone, choline, cilastatin, cimetidine, cisapride, cisplatin, clavulanic acid, clomipramine, clozapine, clonazepam, clonidine, codeine, cholestyramine, cromoglycic acid, cyanocobalamin, cyproterone, desogestrel, dexamethasone, dexpanthenol, dextromethorphan, dextropropoxiphen, diazepam, diclofenac, digoxin, dihydrocodeine, dihydroergotamine, dihydroergotoxin, diltiazem, diphenhydramine, dipyridamole, dipyrone, disopyramide, domperidone, dopamine, doxycycline, enalapril, ephedrine, epinephrine, ergocalciferol, ergotamine, estradiol, ethinylestradiol, etoposide, Eucalyptus globulus, famotidine, felodipine, fenofibrate, fenoterol, fentanyl, flavin mononucleotide, fluconazole, flunarizine, fluorouracil, fluoxetine, flurbiprofen, furosemide, gallopamil, gemfibrozil, Gingko biloba, glibenclamide, glipizide, Glycyrrhiza glabra, grapefruit seed extract, grape seed extract, griseofulvin, guaifenesin, haloperidol, heparin, hyaluronic, hydrochlorothiazide, hydrocodone, hydrocortisone, hydromorphone, ipratropium hydroxide, ibuprofen, imipenem, indomethacin, iohexol, iopamidol, isosorbide dinitrate, isosorbide mononitrate, isotretinoin, ketotifen, ketoconazole, ketoprofen, ketorolac, labetalol, lactulose, lecithin, levocamitine, levodopa, levoglutamide, levonorgestrel, levothyroxine, lidocaine, lipase, imipramine, lisinopril, loperamide, lorazepam, lovastatin, medroxyprogesterone, menthol, methotrexate, methyldopa, methylprednisolone, metoclopramide, metoprolol, miconazole, midazolam, minocycline, minoxidil, misoprostol, morphine, N-methylephedrine, naftidrofuryl, naproxen, nicardipine, nicergoline, nicotinamide, nicotine, nicotinic acid, nifedipine, nimodipine, nitrazepam, nitrendipine, nizatidine, norethisterone, norfloxacin, norgestrel, nortriptyline, omeprazole, ondansetron, pancreatin, panthenol, pantothenic acid, paracetamol, phenobarbital derivatives, metabolites, or mixtures thereof.

23. A medical device comprising the composition of claim 1, wherein the medical device is chosen from:

catheters, cannulae, stents, guide wires, implant devices, contact lenses, IUDs, peristaltic pump chambers, endotracheal tubes, gastroenteric feeding tubes, arteriovenous shunts, condoms, oxygenator and kidney membranes, or pacemaker leads.

24. A medical device comprising a substrate material and a coating on at least part of one or more surfaces of the substrate material and the coating comprises the composition of claim 1.

25. The medical device of claim 24, wherein the coating covers part of at least one surface of the substrate and does not cover another part of the surface.

26. The medical device of claim 25, wherein the part of the surface that is not covered is sufficiently transparent to allow visual inspection of the interior of the article.

27. The medical device of claim 24, wherein the coating comprises multiple coating layers.

28. The medical device of claim 24, wherein the oligodynamic metal compounds are present in a concentration from about 10 to about 15 micrograms per square centimeter of surface area of the medical device.

29. A method for the manufacture of a medical device comprising:

forming a solution, dispersion, or combination thereof comprising the composition of claim 1; and

drying the solution, dispersion or combination thereof to create a solid polymeric medical device,

wherein the medical device is chosen from;

catheters, cannulae, stents, guide wires, implant devices, contact lenses, IUDs, peristaltic pump chambers, endotracheal tubes, gastroenteric feeding tubes, arteriovenous shunts, condoms, oxygenator and kidney membranes, or pacemaker leads.

30. A method for the manufacture of a medical device comprising:

forming the composition of claim 1;

drying the composition; and

processing the composition with the application of heat to form the medical device,

wherein the medical device is chosen from;

catheters, cannulae, stents, guide wires, implant devices, contact lenses, IUDs, peristaltic pump chambers, endotracheal tubes, gastroenteric feeding tubes, arteriovenous shunts, condoms, oxygenator and kidney membranes, or pacemaker leads.

31. A method for the manufacture of a medical device comprising:

(1) forming the composition of claim 1;

(2) compounding the composition formed in (1) with one or more polymers; and

(3) processing the composition formed in (2) with the application of heat to form the medical device,

wherein the medical device is chosen from;

catheters, cannulae, stents, guide wires, implant devices, contact lenses, IUDs, peristaltic pump chambers, endotracheal tubes, gastroenteric feeding tubes, arteriovenous shunts, condoms, oxygenator and kidney membranes, or pacemaker leads.

32. A method for the manufacture of a medical device comprising dipping a form in the composition of claim 1, wherein the medical device is chosen from:

catheters, cannulae, stents, guide wires, implant devices, contact lenses, IUDs, peristaltic pump chambers, endotracheal tubes, gastroenteric feeding tubes, arteriovenous shunts, condoms, oxygenator and kidney membranes, or pacemaker leads.

33. A method for the manufacture of a medical device comprising casting the composition of claim 1 into a preselected shape, wherein the medical device is chosen from:

catheters, cannulae, stents, guide wires, implant devices, contact lenses, IUDs, peristaltic pump chambers, endotracheal tubes, gastroenteric feeding tubes, arteriovenous shunts, condoms, oxygenator and kidney membranes, or pacemaker leads.

34. A method for delivery of more than one oligodynamic metal, salts of oligodynamic metals, oxides of oligodynamic metals, or combinations thereof to a desired location comprising:

providing the composition of claim 1, and

implanting, administering, inserting, or otherwise placing the composition under conditions effective to deliver the oligodynamic metals, salts of oligodynamic metals, oxides of oligodynamic metals, or combinations thereof to the desired location in an organism.

35. A method of treatment of a cell, tissue, or organism, comprising implanting, administering, inserting, or otherwise placing the composition of claim 1 under conditions effective to deliver the oligodynamic metals, salts of oligodynamic metals, oxides of oligodynamic metals, or combinations thereof to the cell, tissue, organism, or a portion of the cell, tissue, or organism.

36. A method of preparing a medical device for delivery of the oligodynamic metals, salts of oligodynamic metals, oxides of oligodynamic metals, or combinations thereof to a cell, tissue, organism, or a portion of the cell, tissue, or organism, the method comprising:

providing the composition of claim 1; and

coating the medical device with said composition, wherein the medical device is chosen from;

catheters, cannulae, stents, guide wires, implant devices, contact lenses, IUDs, peristaltic pump chambers, endotracheal tubes, gastroenteric feeding tubes, arteriovenous shunts, condoms, oxygenator and kidney membranes, or pacemaker leads.